Development of Optimized AAV Serotype Vectors for High-Efficiency Transduction at Further Reduced Doses
about
Evaluation of engineered AAV capsids for hepatic factor IX gene transfer in murine and canine modelsCellular transduction mechanisms of adeno-associated viral vectors.AAV Infection: Protection from Cancer.In vivo genome editing in animals using AAV-CRISPR system: applications to translational research of human disease.
P2860
Development of Optimized AAV Serotype Vectors for High-Efficiency Transduction at Further Reduced Doses
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Development of Optimized AAV S ...... ction at Further Reduced Doses
@en
type
label
Development of Optimized AAV S ...... ction at Further Reduced Doses
@en
prefLabel
Development of Optimized AAV S ...... ction at Further Reduced Doses
@en
P2093
P2860
P356
P1476
Development of Optimized AAV S ...... ction at Further Reduced Doses
@en
P2093
Arun Srivastava
Baozheng Li
P2860
P304
P356
10.1089/HGTB.2016.054
P50
P577
2016-07-18T00:00:00Z